Bin Wu

Company: Cytodigm

Job title: Founder & Chief Executive Officer

Seminars:

PANEL DISCUSSION: Navigating Formulation, CMC, & Regulatory Challenges: Overcoming Barriers to Adopt New Delivery Systems 9:00 am

What challenges do new delivery systems pose for formulation, CMC, and process development, and how can we overcome these to produce a new system at scale, speed and low costs? How can we design a CMC platform that can quickly adapt to the complexity of scaling up a novel formulation while maintaining consistent quality, stability,…Read more

day: Conference Day Two

Redefining Nanoparticle Delivery: PEG-Free LNP Formulation for Targeted & Extrahepatic Applications 1:45 pm

Replacing PEG lipids with natural gangliosides to mitigate immune responses, lower toxicity and improve the overall safety of nanoparticle delivery systems Enabling targeted delivery to bone marrow, lungs and other non-hepatic tissues and cells without the need for antibody conjugation, overcoming key translational hurdles Characterizing particle size, encapsulation efficiency and in vitro/in vivo performance to…Read more

day: Conference Day Two